KORRES NATURAL PRODUCTS

ANNOUNCEMENT re 9M 2013 RESULTS OF KORRES GROUP

KORRES/9M 2013 FINANCIAL RESULTS

 

  • POSITIVE OPERATING CASH FLOW & HIGHER SALES
  • TOP BRAND IN THE PHARMACY CHANNEL IN Q3 2013
  • FURTHER MARKET SHARE INCREASE
  • INCREASING TREND OF SALES IN GREECE

 

Further market share increase in Q3 2013, sales improvement in Greece, higher consolidated Group sales; positive operating cash flow and growth outside Greece in Key markets were the financial highlights of 9M 2013 for the Korres Group.

 

Group consolidated sales in 9M 2013, increased by 0,1%, at 30,9m euro, coming from the KORRES SA positive trend of sales in Greece as well as the positive performance of the key export markets.

 

It is worth mentioning that in Greece, the Group in the pharmacy channel, achieved higher growth than the total market both in Q3 2013 and in 9M 2013, with further market share increase by 50 basis points, reaching 11,2% in Q3 and 10,4% total in 9M. This growth was the result of the positive trend of all product categories in Q3 2013, with major product players being face, make up, sun care and body care.

 

Adjusted earnings before interest, taxes, depreciation and amortization excluding the extraordinary restructuring cost impact-i.e. one off receivables rationalization effect materialized by the group given the foreseen adverse financial environment-(Adjusted EBITDA) reached 6,3m euro in 9M 2013 from 6,6m euro in 9M 2012, due to increased promo actions in the specific period. Earnings before interest, taxes, depreciation and amortization (EBITDA), after deducting restructuring costs reached 4,0m euro in 9M 2013.

 

The Group achieved positive operating cash flow of 4,6m euro from -0,7m euro in 9M 2012, as a result of the operating cost improvement and the management efforts towards rationalization of working capital.

 

Net after tax and minority results reached -1,9m euro in 9M 2013 from 1,4m euro in the corresponding period of 2012. Excluding the restructuring cost mentioned above, net profit after tax and minority rights were positive 0,3m euro.

 

Outside Greece, the group continues its efforts to increase its total sales both in North America and in the key European markets of Germany, France, UK, Russia and Scandinavia. The group's objective is to further grow its brand awareness and presence in pharmacies and semi selective POS through new product categories, new products and focused promotional activities.

 

For more information:

INVESTOR RELATIONS / Athina Lagou / Τ: (+30) 213 018 8905, E: athina.lagou@korres.com

PUBLIC RELATIONS / George Anthoulakis / T (+30) 2130 188835 / E george.anthoulakis@korres.com